This Solicitation opportunity from Government of Canada was posted on January 6, 2023. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Highly Pathogenic Avian Influenza Outbreak Testing Services
Closed
WS3770350990CanadaSubmission Closed
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
General Info
Agency
Government of Canada → Department of Public Works and Government ServicesView Agency
NAICS
N/A
Place of Performance
*British Columbia, CANSet-Aside
NONE
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
PhaseClosed
Submission Closed
Organization & Contact Information
Show more
AgencyGovernment of Canada → Department of Public Works and Government Services
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Department of Public Works and Government Services
View Agency ProfileOffice AddressN/A
Contacts
Full Description
Show more
AMENDMENT TO CLOSING TIME: Please disregard the Ariba Discovery posting response deadline closing time and Buyandsell posting closing time. All required supporting documentation and bid submission must be submitted on January 23, 2023 by 2:00pm EST. All bids submitted after 2:00pm EST will result in the bid being declared non-responsive.
The Canadian Food Inspection Agency (CFIA) has a requirement for Avian Influenza sample testing services from a certified lab in the province of British Columbia. The Contractor will perform the Real- time Reverse Transcription Polymerase Chain Reaction (RRT-PCR) testing for the detection of Avian Influenza, produce Reports of analysis (ROA), and inform the CFIA with a turnaround time for results within 24-hours after receipt of the sample. The testing is required in support of the CFIA’s mandate to respond and, where possible, mitigate the impact of this disease.